1. Home
  2. CDRE vs GPCR Comparison

CDRE vs GPCR Comparison

Compare CDRE & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDRE
  • GPCR
  • Stock Information
  • Founded
  • CDRE 2012
  • GPCR 2016
  • Country
  • CDRE United States
  • GPCR United States
  • Employees
  • CDRE N/A
  • GPCR N/A
  • Industry
  • CDRE Industrial Specialties
  • GPCR
  • Sector
  • CDRE Health Care
  • GPCR
  • Exchange
  • CDRE Nasdaq
  • GPCR Nasdaq
  • Market Cap
  • CDRE 1.3B
  • GPCR 1.1B
  • IPO Year
  • CDRE 2021
  • GPCR 2023
  • Fundamental
  • Price
  • CDRE $33.79
  • GPCR $18.16
  • Analyst Decision
  • CDRE Buy
  • GPCR Strong Buy
  • Analyst Count
  • CDRE 2
  • GPCR 7
  • Target Price
  • CDRE $37.50
  • GPCR $76.17
  • AVG Volume (30 Days)
  • CDRE 232.1K
  • GPCR 696.2K
  • Earning Date
  • CDRE 08-08-2025
  • GPCR 08-07-2025
  • Dividend Yield
  • CDRE 1.13%
  • GPCR N/A
  • EPS Growth
  • CDRE N/A
  • GPCR N/A
  • EPS
  • CDRE 0.95
  • GPCR N/A
  • Revenue
  • CDRE $559,807,000.00
  • GPCR N/A
  • Revenue This Year
  • CDRE $13.31
  • GPCR N/A
  • Revenue Next Year
  • CDRE $7.96
  • GPCR N/A
  • P/E Ratio
  • CDRE $35.64
  • GPCR N/A
  • Revenue Growth
  • CDRE 10.06
  • GPCR N/A
  • 52 Week Low
  • CDRE $27.07
  • GPCR $13.22
  • 52 Week High
  • CDRE $40.28
  • GPCR $45.37
  • Technical
  • Relative Strength Index (RSI)
  • CDRE 58.03
  • GPCR 32.49
  • Support Level
  • CDRE $32.15
  • GPCR $17.76
  • Resistance Level
  • CDRE $32.97
  • GPCR $20.25
  • Average True Range (ATR)
  • CDRE 0.74
  • GPCR 0.96
  • MACD
  • CDRE 0.14
  • GPCR -0.05
  • Stochastic Oscillator
  • CDRE 98.62
  • GPCR 13.09

About CDRE Cadre Holdings Inc.

Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: